Literature DB >> 21603312

Imaging of gastroenteropancreatic neuroendocrine tumors.

Eik Hock Tan1, Cher Heng Tan.   

Abstract

Imaging of gastroenteropancreatic neuroendocrine tumors can be broadly divided into anatomic and functional techniques. Anatomic imaging determines the local extent of the primary lesion, providing crucial information required for surgical planning. Functional imaging, not only determines the extent of metastatic disease spread, but also provides important information with regard to the biologic behavior of the tumor, allowing clinicians to decide on the most appropriate forms of treatment. We review the current literature on this subject, with emphasis on the strengths of each imaging modality.

Entities:  

Keywords:  Magnetic resonance imaging; Neuroendocrine tumor; Positron emission tomography; Somatostatin receptor scintigraphy

Year:  2011        PMID: 21603312      PMCID: PMC3095463          DOI: 10.5306/wjco.v2.i1.28

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  88 in total

1.  Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.

Authors:  Marcus Henze; Jochen Schuhmacher; Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss; Helmut R Mäcke; Michael Eisenhut; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

2.  Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Authors:  M Hofmann; H Maecke; R Börner; E Weckesser; P Schöffski; L Oei; J Schumacher; M Henze; A Heppeler; J Meyer; H Knapp
Journal:  Eur J Nucl Med       Date:  2001-10-31

3.  Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.

Authors:  Reinhard Bos; Jacobus J M van Der Hoeven; Elsken van Der Wall; Petra van Der Groep; Paul J van Diest; Emile F I Comans; Urvi Joshi; Gregg L Semenza; Otto S Hoekstra; Adriaan A Lammertsma; Carla F M Molthoff
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

4.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Authors:  Jörg Kowalski; Marcus Henze; Jochen Schuhmacher; Helmut R Mäcke; Michael Hofmann; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2003 Jan-Feb       Impact factor: 3.488

5.  Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model.

Authors:  Sylvie Froidevaux; Alex N Eberle; Martine Christe; Lazar Sumanovski; Axel Heppeler; Jörg S Schmitt; Klaus Eisenwiener; Christoph Beglinger; Helmut R Mäcke
Journal:  Int J Cancer       Date:  2002-04-20       Impact factor: 7.396

6.  Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification.

Authors:  Maurizio Mezzetti; Federico Raveglia; Tiziana Panigalli; Luigi Giuliani; Fabio Lo Giudice; Stefano Meda; Serena Conforti
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

7.  CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas.

Authors:  Hervé Gouya; Olivier Vignaux; Joelle Augui; Bertrand Dousset; Laurent Palazzo; André Louvel; Stanislas Chaussade; Paul Legmann
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

8.  Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.

Authors:  Alexander Becherer; Monica Szabó; Georgios Karanikas; Patrick Wunderbaldinger; Peter Angelberger; Markus Raderer; Amir Kurtaran; Robert Dudczak; Kurt Kletter
Journal:  J Nucl Med       Date:  2004-07       Impact factor: 10.057

9.  Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.

Authors:  Jochen Mundschenk; Nicole Unger; Stefan Schulz; Volker Höllt; Solveig Schulz; Rainer Steinke; Hendrik Lehnert
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

10.  Localization of pancreatic endocrine tumors by endoscopic ultrasonography.

Authors:  T Rösch; C J Lightdale; J F Botet; G A Boyce; M V Sivak; K Yasuda; N Heyder; L Palazzo; H Dancygier; V Schusdziarra
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

View more
  20 in total

1.  Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging.

Authors:  Ananda Kumar Kanduluru; Madduri Srinivasarao; Charity Wayua; Philip S Low
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Imaging as a diagnostic and therapeutic tool in clinical oncology.

Authors:  Eddie Yin-Kwee Ng; Rajendra U Acharya
Journal:  World J Clin Oncol       Date:  2011-04-10

3.  Anal Neuroendocrine Tumor Masquerading as External Hemorrhoids: A Case Report.

Authors:  Muhammad Khan; Ahmed Dirweesh; Chikezie Alvarez; Herbert Conaway; Robert Moser
Journal:  Gastroenterology Res       Date:  2017-02-21

4.  State-of-the-art PET/CT of the pancreas: current role and emerging indications.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Onofrio A Catalano; Alexander R Guimaraes; Michael A Blake
Journal:  Radiographics       Date:  2012 Jul-Aug       Impact factor: 5.333

Review 5.  A new era for the systemic therapy of neuroendocrine tumors.

Authors:  Jennifer R Eads; Neal J Meropol
Journal:  Oncologist       Date:  2012-02-21

6.  The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.

Authors:  Marco De Martino; Simona Pellecchia; Francesco Esposito; Nadia Tosti; Cristina Quintavalle; Serenella Eppenberger-Castori; Vincenza Carafa; Alberto Righi; Paolo Chieffi; Alfredo Fusco; Luigi Maria Terracciano; Pierlorenzo Pallante
Journal:  Cell Cycle       Date:  2022-03-14       Impact factor: 5.173

Review 7.  Laparoscopic resection of pancreatic neuroendocrine tumors.

Authors:  Abbas Al-Kurd; Katya Chapchay; Simona Grozinsky-Glasberg; Haggi Mazeh
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 8.  Neoplastic stomach lesions and their mimickers: spectrum of imaging manifestations.

Authors:  Vivek Virmani; Ashish Khandelwal; Vineeta Sethi; Margret Fraser-Hill; Najla Fasih; Ania Kielar
Journal:  Cancer Imaging       Date:  2012-08-10       Impact factor: 3.909

9.  Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases.

Authors:  Rachel Jorge D Cossetti; Regis Otaviano França Bezerra; Brenda Gumz; Adriana Telles; Frederico P Costa
Journal:  World J Surg Oncol       Date:  2012-05-16       Impact factor: 2.754

10.  Duodenal somatostatinoma: a case report and review of the literature.

Authors:  Oguz Koc; Yigit Duzkoylu; Yavuz Selim Sari; Hasan Bektas; Gungor Uzum; Vahit Tunali; Esra Pasaoglu
Journal:  J Med Case Rep       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.